No takes yet. Share an insight, caveat, or question.
Narrative review characterizes primary immunodeficiencies driven by PI3K/AKT/mTOR defects as immune TOR-opathies, highlighting pathways for targeted therapeutic intervention.
Jung et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: